Ontology highlight
ABSTRACT:
SUBMITTER: Jaroslawski S
PROVIDER: S-EPMC5956285 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
Jarosławski Szymon S Auquier Pascal P Borissov Borislav B Dussart Claude C Toumi Mondher M
Journal of market access & health policy 20180212 1
<b>Background</b>: Claims included in package inserts (PIs) for medicinal products approved by the US Food and Drug Administration (FDA) constitute the regulatory definition of drugs' benefits and risks. <b>Objective</b>: We sought to assess the usage of patient-reported outcome (PRO) claims in a comprehensive set of US FDA orphan drug approvals dated between 1/1/2012 and 31/12/2016, and characterize them. <b>Study design</b>: Orphan drug approval documentation was obtained from the US FDA websi ...[more]